TG THERAPEUTICS, INC. Increase (Decrease) in Other Accrued Liabilities
TG THERAPEUTICS, INC. (TGTX) reported Increase (Decrease) in Other Accrued Liabilities of -$1.19 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2023-08-04
- TG THERAPEUTICS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2023-06-30 was -$594.00K.
- TG THERAPEUTICS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2023-03-31 was -$593.00K.
- TG THERAPEUTICS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2022-12-31 was -$591.00K.
- TG THERAPEUTICS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2022-09-30 was -$746.00K.
- TG THERAPEUTICS, INC. increase (decrease) in other accrued liabilities for fiscal 2022 was -$2.33M.
- TG THERAPEUTICS, INC. increase (decrease) in other accrued liabilities for fiscal 2021 was -$2.01M.
- TG THERAPEUTICS, INC. increase (decrease) in other accrued liabilities for fiscal 2020 was -$1.99M.
- TG THERAPEUTICS, INC. increase (decrease) in other accrued liabilities for fiscal 2019 was -$1.55M.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month | Increase (Decrease) in Other Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2023-06-30 | -$594.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$1.19M 10-Q · filed 2023-08-04 | -$1.78M derived: sum of 3 quarters · filed 2023-08-04 | -$2.52M derived: sum of 4 quarters · filed 2023-08-04 | |
| 2023-03-31 | -$593.00K 10-Q · filed 2023-05-08 | -$1.18M derived: sum of 2 quarters · filed 2023-05-08 | -$1.93M derived: sum of 3 quarters · filed 2023-05-08 | -$2.43M derived: sum of 4 quarters · filed 2023-08-04 | |
| 2022-12-31 | -$591.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$1.34M derived: sum of 2 quarters · filed 2023-03-01 | -$1.84M derived: sum of 3 quarters · filed 2023-08-04 | -$2.33M 10-K · filed 2023-03-01 | |
| 2022-09-30 | -$746.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.25M derived: sum of 2 quarters · filed 2023-08-04 | -$1.74M 10-Q · filed 2022-11-09 | -$2.25M derived: sum of 4 quarters · filed 2023-08-04 | |
| 2022-06-30 | -$503.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$995.00K 10-Q · filed 2023-08-04 | -$1.50M derived: sum of 3 quarters · filed 2023-08-04 | -$2.00M derived: sum of 4 quarters · filed 2023-08-04 | |
| 2022-03-31 | -$492.00K 10-Q · filed 2023-05-08 | -$997.00K derived: sum of 2 quarters · filed 2023-05-08 | -$1.50M derived: sum of 3 quarters · filed 2023-05-08 | -$2.00M derived: sum of 4 quarters · filed 2023-05-08 | |
| 2021-12-31 | -$505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$1.01M derived: sum of 2 quarters · filed 2023-03-01 | -$1.50M derived: sum of 3 quarters · filed 2023-03-01 | -$2.01M 10-K · filed 2023-03-01 | |
| 2021-09-30 | -$501.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.00M derived: sum of 2 quarters · filed 2022-11-09 | -$1.51M 10-Q · filed 2022-11-09 | -$2.13M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$499.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$1.01M 10-Q · filed 2022-08-09 | -$1.63M derived: sum of 3 quarters · filed 2023-03-01 | -$558.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | -$507.00K 10-Q · filed 2022-05-10 | -$1.14M derived: sum of 2 quarters · filed 2023-03-01 | -$59.00K derived: sum of 3 quarters · filed 2023-03-01 | -$528.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$628.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $448.00K derived: sum of 2 quarters · filed 2023-03-01 | -$21.00K derived: sum of 3 quarters · filed 2023-03-01 | -$1.99M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $607.00K derived: sum of 2 quarters · filed 2021-11-08 | -$1.36M 10-Q · filed 2021-11-08 | -$1.78M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | -$469.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$2.44M 10-Q · filed 2021-08-06 | -$2.85M derived: sum of 3 quarters · filed 2022-03-01 | -$3.31M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$1.97M 10-Q · filed 2021-05-10 | -$2.39M derived: sum of 2 quarters · filed 2022-03-01 | -$2.84M derived: sum of 3 quarters · filed 2022-03-01 | -$3.18M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$419.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$870.00K derived: sum of 2 quarters · filed 2022-03-01 | -$1.21M derived: sum of 3 quarters · filed 2022-03-01 | -$1.55M 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$451.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$790.00K derived: sum of 2 quarters · filed 2020-11-09 | -$1.13M 10-Q · filed 2020-11-09 | -$1.13M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | -$339.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$678.00K 10-Q · filed 2020-08-10 | -$678.00K derived: sum of 3 quarters · filed 2021-03-01 | -$678.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | -$339.00K 10-Q · filed 2020-05-11 | -$339.00K derived: sum of 2 quarters · filed 2021-03-01 | -$339.00K derived: sum of 3 quarters · filed 2021-03-01 | -$339.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 | $18.35M 10-K · filed 2019-03-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-10 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-03-02 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |